KUALA LUMPUR: Bintai Kinden Corporation Bhd
’s subsidiary has picked ASX-listed IEC Properties Pty Ltd as sole distributor for the Ii-Key-SARS-CoV-2 Covid-19 vaccine in Australia and New Zealand.
Bintai Healthcare Sdn Bhd had on Thursday signed an MoU with IEC – a unit of International Equities Corporation Ltd to further negotiate on the terms and conditions to grant IEC the exclusive distribution rights.
Already a subscriber? Log in
The Star 6.6 DEAL: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
